Drug Approval | March 13, 2024
European Commission approves Pfizer’s Prevenar 20 to help protect infants and children against pneumococcal disease
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
_256_275.jpg)